LMNA Gene Limb-girdle muscular dystrophy autosomal dominant type 1B Genetic Test
Introduction
The LMNA gene is associated with a specific type of muscular dystrophy called limb-girdle muscular dystrophy, autosomal dominant type 1B (LGMD1B). This type of muscular dystrophy is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children.
Test Details
- Test Name: LMNA Gene Limb-girdle muscular dystrophy autosomal dominant type 1B Genetic Test
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for LMNA Gene Limb-girdle muscular dystrophy, autosomal dominant type 1B NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Limb-girdle muscular dystrophy, autosomal dominant type 1B
Test Methodology
NGS stands for next-generation sequencing, which is a technology used for genetic testing. NGS genetic testing can analyze multiple genes simultaneously and can be used to identify mutations or variations in the LMNA gene that are associated with LGMD1B. This test can help confirm a diagnosis of LGMD1B and provide information about the specific genetic changes that are present. It is important to note that a genetic test alone may not be sufficient to diagnose LGMD1B, as the clinical presentation and other factors also need to be considered.
Genetic Counseling
Genetic counseling is recommended before and after undergoing genetic testing to discuss the implications of the results and to address any concerns or questions.
| Test Name | LMNA Gene Limb-girdle muscular dystrophy autosomal dominant type 1B Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for LMNA Gene Limb-girdle muscular dystrophy, autosomal dominant type 1B NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Limb-girdle muscular dystrophy, autosomal dominant type 1B |
| Test Details | The LMNA gene is associated with a specific type of muscular dystrophy called limb-girdle muscular dystrophy, autosomal dominant type 1B (LGMD1B). This type of muscular dystrophy is inherited in an autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the condition on to each of their children. NGS stands for next-generation sequencing, which is a technology used for genetic testing. NGS genetic testing can analyze multiple genes simultaneously and can be used to identify mutations or variations in the LMNA gene that are associated with LGMD1B. This test can help confirm a diagnosis of LGMD1B and provide information about the specific genetic changes that are present. It is important to note that a genetic test alone may not be sufficient to diagnose LGMD1B, as the clinical presentation and other factors also need to be considered. Genetic counseling is recommended before and after undergoing genetic testing to discuss the implications of the results and to address any concerns or questions. |
